Mr. Michael Simon reports

AURORA CANNABIS LAUNCHES FIRST DOMESTICALLY GROWN MEDICAL CANNABIS BRAND IN GERMANY UNDER NEW CULTIVATION LICENSE

Aurora Cannabis Inc. has launched the company's first German-cultivated medical cannabis product, under the brand IndiMed. Manufactured at Aurora's leading EU-GMP (European Union good manufacturing practice) facility in Leuna, Germany, the new brand offers a supply of high-quality, locally grown and sold medical cannabis for the country's expanding patient base.

"Aurora is proud to deliver to the rapidly growing German market our first domestically produced medical cannabis product -- a significant step forward since Germany's move to decriminalize cannabis earlier this year," said Michael Simon, president, Aurora Europe (interim). "As one of three facilities licensed to cultivate in Germany, we are uniquely positioned to offer domestic product from our EU-GMP facility in Leuna, Germany, which operates within Aurora's global manufacturing network. It is through our expertise in cultivation and deep commitment to science and innovation that we introduce IndiMed to the German patients."

The premium product launching from the IndiMed brand is Island Sweet Skunk (dried flower, sativa, 20 per cent THC (tetrahydrocannabinol) and less than 1 per cent CBD (cannabidiol)). Product is expected to be available on Jan. 27, 2025. IndiMed is cultivated under GACP (good agricultural and collection practice) and EU-GMP guidelines to ensure pharmaceutical-grade quality. The flowers are harvested by hand, dried under controlled conditions, and tested in the state-of-the-art laboratory for purity and active ingredient content.

Aurora leads the global medical cannabis industry with unmatched expertise, driving innovation and progress. Its steadfast commitment to growth in the dynamic German market cements its position as the industry's unrivalled leader.

Aurora's expertise in navigating complex European regulatory frameworks and manufacturing high-quality medical cannabis positions the company as the preferred leader to drive progress in the German market with confidence. By continually setting new global benchmarks, Aurora reinforces its status as the world's largest medical cannabis company operating in nationally legal markets.

About Aurora Cannabis Inc.

Aurora is opening the world to cannabis, serving both the medical and consumer markets across Canada, Europe, Australia and South America. Headquartered in Edmonton, Alta., Aurora is a pioneer in global cannabis, dedicated to helping people improve their lives. The company's adult-use brand portfolio includes Drift, San Rafael '71, Daily Special, Tasty's, Being and Greybeard. Medical cannabis brands include MedReleaf, CanniMed, Aurora and Whistler Medical Marijuana Co. as well as international brands Pedanios, IndiMed and CraftPlant. Aurora also has a controlling interest in Bevo Farms Ltd., North America's leading supplier of propagated agricultural plants. Driven by science and innovation and with a focus on high-quality cannabis products, Aurora's brands continue to break through as industry leaders in the medical, wellness and adult recreational markets wherever they are launched.

Aurora's common shares trade on the Nasdaq Stock Market and the Toronto Stock Exchange under the symbol ACB.

We seek Safe Harbor.